scholarly article | Q13442814 |
P2093 | author name string | Xianlin Han | |
Baris Ercal | |||
D André d'Avignon | |||
Peter A Crawford | |||
Gary J Patti | |||
Mark J Graham | |||
Patrycja Puchalska | |||
YingJu Chang | |||
Shannon E Martin | |||
P2860 | cites work | Ketone body metabolism in lean and obese women | Q46777742 |
Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice | Q47439029 | ||
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases | Q47779219 | ||
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis | Q49797701 | ||
A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo. | Q51174952 | ||
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy. | Q51243781 | ||
Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. | Q51330295 | ||
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. | Q51466282 | ||
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. | Q51479731 | ||
Changes induced by exercise in rates of turnover and oxidation of ketone bodies in fasting man | Q51665843 | ||
Ketone body metabolism in lean male adults during short-term starvation, with particular reference to forearm muscle metabolism | Q68470721 | ||
Medium chain fatty acids as specific substrates for diglyceride acyltransferase in cultured hepatocytes | Q71741133 | ||
Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry | Q28267459 | ||
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome | Q28504726 | ||
Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative | Q30917315 | ||
Alterations in mouse brain lipidome after disruption of CST gene: a lipidomics study | Q33857084 | ||
Exogenous Fatty Acids Are the Preferred Source of Membrane Lipids in Proliferating Fibroblasts. | Q33904647 | ||
Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. | Q33916541 | ||
Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment | Q34042546 | ||
Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure | Q34308079 | ||
Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. | Q34404106 | ||
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. | Q34518314 | ||
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | Q34673134 | ||
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia | Q35145496 | ||
Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo | Q35859172 | ||
Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver | Q35958436 | ||
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver | Q36335957 | ||
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux | Q36430696 | ||
Regulation of Liver Metabolism by Autophagy | Q36505751 | ||
Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease | Q36856713 | ||
Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism | Q37066004 | ||
Lactate metabolism is associated with mammalian mitochondria | Q37348191 | ||
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans | Q37379144 | ||
Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: Implications in pathology | Q37621738 | ||
X13CMS: global tracking of isotopic labels in untargeted metabolomics | Q37696816 | ||
Biological function of the cellular lipid BMP-BMP as a key activator for cholesterol sorting and membrane digestion | Q37817029 | ||
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies | Q38705659 | ||
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes | Q38729780 | ||
Management of NAFLD: a stage-based approach | Q38747405 | ||
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics | Q39126658 | ||
α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate | Q40404245 | ||
Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions | Q40584025 | ||
Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis | Q40960591 | ||
Effects of insulin on ketogenesis following fasting in lean and obese men. | Q44957381 | ||
De novo biosynthesis of the late endosome lipid, bis(monoacylglycero)phosphate | Q45345671 | ||
Adipose tissue fatty acid metabolism in insulin-resistant men. | Q46574444 | ||
P433 | issue | 12 | |
P577 | publication date | 2018-06-21 | |
P1433 | published in | JCI insight | Q27727187 |
P1476 | title | Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome | |
P478 | volume | 3 |
Q93200111 | Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis |
Q90364064 | Hepatocyte-specific Sirt6 deficiency impairs ketogenesis |
Q90229814 | Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver |
Q89930042 | Lipids and Ketones Dominate Metabolism at the Expense of Glucose Control in Pulmonary Arterial Hypertension: A Hyperglycemic Clamp and Metabolomics Study |
Q64071287 | Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans |
Q90047748 | Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver |
Q92548346 | Systems-level analysis of isotopic labeling in untargeted metabolomic data by X13CMS |
Search more.